![]() BMS-777607 |
|||
2455-5 | Biovision | EUR 185 |
![]() BMS-911543 |
|||
2630-1 | Biovision | EUR 142 |
![]() BMS-911543 |
|||
2630-5 | Biovision | EUR 414 |
![]() BMS-754807 |
|||
2631-1 | Biovision | EUR 131 |
![]() BMS-754807 |
|||
2631-5 | Biovision | EUR 370 |
![]() BMS-303141 |
|||
2821-10 | Biovision | EUR 207 |
![]() BMS-303141 |
|||
2821-50 | Biovision | EUR 686 |
![]() BMS-754807 |
|||
A1185-100 | ApexBio | 100 mg | EUR 862 |
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies. |
![]() BMS-754807 |
|||
A1185-25 | ApexBio | 25 mg | EUR 340 |
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies. |
![]() BMS-754807 |
|||
A1185-5 | ApexBio | 5 mg | EUR 125 |
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies. |
![]() BMS-754807 |
|||
A1185-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 154 |
Description: BMS-754807 is a potent and small molecular inhibitor which targets the IGF-1R/IR family kinases with Ki <2 nmol/L[1]. The efficacy of BMS-754807 on normal tissues and tumor cell cycle is believed to be different from the effects of continuous inhibition by anti-IGF-1R antibodies. |
![]() BMS-599626 |
|||
1614-1 | Biovision | EUR 213 |
![]() BMS-599626 |
|||
1614-5 | Biovision | EUR 615 |
![]() BMS-378806 |
|||
B1533-10 | ApexBio | 10 mg | EUR 305 |
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
![]() BMS-378806 |
|||
B1533-100 | ApexBio | 100 mg | EUR 1186 |
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
![]() BMS-378806 |
|||
B1533-5 | ApexBio | 5 mg | EUR 189 |
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
![]() BMS-378806 |
|||
B1533-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 235 |
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
![]() BMS-378806 |
|||
B1533-50 | ApexBio | 50 mg | EUR 838 |
Description: BMS-378806 is a novel attachment inhibitor of HIV with EC50 values of 2.68±1.64nM, 26.5±3.5nM. |
![]() BMS-626529 |
|||
B1557-25 | Biovision | EUR 805 |
![]() BMS-626529 |
|||
B1557-5 | Biovision | EUR 240 |
![]() BMS-708163 |
|||
B1622-25 | Biovision | EUR 805 |
![]() BMS-708163 |
|||
B1622-5 | Biovision | EUR 240 |
![]() BMS-582949 |
|||
B1704-1 | Biovision | EUR 185 |
![]() BMS-582949 |
|||
B1704-5 | Biovision | EUR 588 |
![]() BMS-986205 |
|||
B1839-25 | Biovision | EUR 805 |
![]() BMS-986205 |
|||
B1839-5 | Biovision | EUR 240 |
![]() BMS-536924 |
|||
B1908-1 | Biovision | EUR 142 |
![]() BMS-536924 |
|||
B1908-5 | Biovision | EUR 414 |
![]() BMS-986158 |
|||
B2021-1 | Biovision | EUR 142 |
![]() BMS-986158 |
|||
B2021-5 | Biovision | EUR 414 |
![]() BMS-794833 |
|||
B2055-5 | Biovision | EUR 196 |
![]() BMS-986020 |
|||
B2290-25 | Biovision | EUR 631 |
![]() BMS-986020 |
|||
B2290-5 | Biovision | EUR 196 |
![]() BMS-663068 |
|||
B2299-25 | Biovision | EUR 756 |
![]() BMS-663068 |
|||
B2299-5 | Biovision | EUR 229 |
![]() BMS-986142 |
|||
B2420-1 | Biovision | EUR 196 |
![]() BMS-986142 |
|||
B2420-5 | Biovision | EUR 631 |
![]() BMS 753 |
|||
B5438-10 | ApexBio | 10 mg | EUR 350 |
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis. |
![]() BMS 753 |
|||
B5438-50 | ApexBio | 50 mg | EUR 1266 |
Description: Ki : 2 nM for RAR? Three retinoic acid receptors (RAR?, RAR? and RAR? and three retinoid X receptors, members of the nuclear receptor (NR) superfamily, mediate the biological effects of retinoic acids upon development, cell differentiation and proliferation, and homeostasis. |
![]() BMS-303141 |
|||
B1079-10 | ApexBio | 10 mg | EUR 148 |
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids. |
![]() BMS-303141 |
|||
B1079-25 | ApexBio | 25 mg | EUR 247 |
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids. |
![]() BMS-303141 |
|||
B1079-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 134 |
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids. |
![]() BMS-303141 |
|||
B1079-50 | ApexBio | 50 mg | EUR 398 |
Description: BMS-303141 is a potent inhibitor of ATP-citrate lyase with IC50 value of 0.13 ?M [1]. ATP-citrate lyase (ACL) is a cytosolic enzyme that responsible for the production of cytosolic acetyl-CoA, a precursor required for de novo biosyntheses of cholesterol and fatty acids. |
![]() BMS-794833 |
|||
B1438-10 | ApexBio | 10 mg | EUR 253 |
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
![]() BMS-794833 |
|||
B1438-5 | ApexBio | 5 mg | EUR 164 |
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
![]() BMS-794833 |
|||
B1438-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 177 |
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
![]() BMS-794833 |
|||
B1438-50 | ApexBio | 50 mg | EUR 833 |
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
![]() BMS-794833 |
|||
B1438-S | ApexBio | Evaluation Sample | EUR 81 |
Description: BMS-794833 is a potent ATP competitive, dual inhibitor of c-Met and VEGFR2 (IC50 = 1.7 nM and 15 nM, respectively). It also has inhibitory effect on Ron, Axl and Flt3 (IC50 50% TGI for at least one tumor doubling time without significant toxicity in 14 days. |
![]() BMS-817378 |
|||
B5862-10 | ApexBio | 10 mg | EUR 311 |
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
![]() BMS-817378 |
|||
B5862-5 | ApexBio | 5 mg | EUR 189 |
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
![]() BMS-817378 |
|||
B5862-50 | ApexBio | 50 mg | EUR 833 |
Description: Description:IC50: 1.7 nM/15 nM for Met/VEGFR2 The signaling pathway of the receptor tyrosine kinase MET and its ligand hepatocyte growth factor is important for cell growth, survival, and motility. |
![]() BMS-582949 |
|||
B6187-1 | ApexBio | 1 mg | EUR 145 |
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?. |
![]() BMS-582949 |
|||
B6187-25 | ApexBio | 25 mg | EUR 777 |
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?. |
![]() BMS-582949 |
|||
B6187-5 | ApexBio | 5 mg | EUR 290 |
Description: IC50: 13 nMBMS-582949 is a p38 MAPK inhibitorp38R MAP kinase plays a key role in regulating the biosynthesis of various inflammatory cytokines, such as tumor necrosis factor alpha and interleukin-1?. |
![]() BMS-833923 |
|||
9547-25 | Biovision | EUR 544 |
![]() BMS-833923 |
|||
9547-5 | Biovision | EUR 175 |
![]() BMS-299897 |
|||
9606-25 | Biovision | EUR 675 |
![]() BMS-299897 |
|||
9606-5 | Biovision | EUR 207 |
![]() Bms 626529 |
|||
20-abx182383 | Abbexa |
|
|
|
![]() BMS 687453 |
|||
C3544-10 | ApexBio | 10 mg | EUR 328 |
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist. |
![]() BMS 687453 |
|||
C3544-25 | ApexBio | 25 mg | EUR 659 |
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist. |
![]() BMS 687453 |
|||
C3544-5 | ApexBio | 5 mg | EUR 206 |
Description: IC50: 10 nM for human PPAR?BMS 687453 is a PPAR? agonist. |
![]() BMS 191011 |
|||
B7146-10 | ApexBio | 10 mg | EUR 232 |
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients. |
![]() BMS 191011 |
|||
B7146-25 | ApexBio | 25 mg | EUR 483 |
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients. |
![]() BMS 191011 |
|||
B7146-5 | ApexBio | 5 mg | EUR 145 |
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients. |
![]() BMS 191011 |
|||
B7146-50 | ApexBio | 50 mg | EUR 818 |
Description: BMS 191011 is a maxi-K channel opener [1].Maxi-K channels consist of a pore-forming ? subunit and a regulatory ? subunit. Maxi-K channels are of a high Ca2+ sensitivity [2].Bath application of BMS-191011 at a concentration of 20 ?M strongly reduced the calcium transients. |
![]() BMS 193885 |
|||
B7327-10 | ApexBio | 10 mg | EUR 454 |
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis. |
![]() BMS 193885 |
|||
B7327-50 | ApexBio | 50 mg | EUR 1714 |
Description: BMS-193885 is a potent and selective neuropeptide Y1 receptor antagonist with IC50 of 5.9nM.Neuropeptide Y receptor 1 is G-protein coupled receptors and implicated in the modulation of food intake and energy homeostasis. |
![]() BMS 453 |
|||
B7396-10 | ApexBio | 10 mg | EUR 270 |
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids. |
![]() BMS 453 |
|||
B7396-25 | ApexBio | 25 mg | EUR 537 |
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids. |
![]() BMS 453 |
|||
B7396-5 | ApexBio | 5 mg | EUR 171 |
Description: BMS 453 is a synthetic RAR (retinoic acid receptor) antagonist [1]. The retinoic acid receptors (RAR?, RAR?, RAR?) belong to steroid nuclear receptor superfamily and the expressions of retinoid receptor RAR? and RAR? are correlated with the antiproliferative effects of retinoids. |
![]() BMS 961 |
|||
B7397-10 | ApexBio | 10 mg | EUR 366 |
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription. |
![]() BMS 961 |
|||
B7397-50 | ApexBio | 50 mg | EUR 1347 |
Description: BMS961 is a potent and selective retinoic acid receptor gamma (RAR?) agonist with IC50 values of 30 nM.RAR? belongs to the family of nuclear receptors which regulates transcription. |
![]() BMS 493 |
|||
B7415-10 | ApexBio | 10 mg | EUR 293 |
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs. |
![]() BMS 493 |
|||
B7415-25 | ApexBio | 25 mg | EUR 598 |
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs. |
![]() BMS 493 |
|||
B7415-5 | ApexBio | 5 mg | EUR 196 |
Description: BMS493 is an inverse agonist of pan-retinoic acid receptors (pan-RARs). This compound has been shown to increase nuclear corepressor (NCoR) interaction with RARs. |
![]() BMS 195614 |
|||
B7459-10 | ApexBio | 10 mg | EUR 311 |
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5]. |
![]() BMS 195614 |
|||
B7459-5 | ApexBio | 5 mg | EUR 197 |
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5]. |
![]() BMS 195614 |
|||
B7459-50 | ApexBio | 50 mg | EUR 1181 |
Description: BMS 195614 is a selective RAR? antagonist [1]. It can bind to the RAR? subunit [5]. |
![]() BMS 309403 |
|||
B7794-10 | ApexBio | 10 mg | EUR 189 |
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor. |
![]() BMS 309403 |
|||
B7794-25 | ApexBio | 25 mg | EUR 351 |
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor. |
![]() BMS 309403 |
|||
B7794-5 | ApexBio | 5 mg | EUR 131 |
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor. |
![]() BMS 309403 |
|||
B7794-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 212 |
Description: BMS309403 is specifically designed to target FABP4 with a Ki value less than 2 nM. It is a potent and selective FABP4 inhibitor. |
![]() BMS-707035 |
|||
A4069-10 | ApexBio | 10 mg | EUR 195 |
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell. |
![]() BMS-707035 |
|||
A4069-100 | ApexBio | 100 mg | EUR 885 |
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell. |
![]() BMS-707035 |
|||
A4069-5 | ApexBio | 5 mg | EUR 131 |
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell. |
![]() BMS-707035 |
|||
A4069-50 | ApexBio | 50 mg | EUR 560 |
Description: BMS-707035 is a specific HIV-I integrase (IN) inhibitor with IC50 value of 15 nM [1].Retroviral IN is an enzyme produced by a retrovirus (such as HIV) that enables its genetic material to be integrated into the DNA of the infected cell. |
![]() BMS-911543 |
|||
A4152-10 | ApexBio | 10 mg | EUR 400 |
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. |
![]() BMS-911543 |
|||
A4152-25 | ApexBio | 25 mg | EUR 595 |
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. |
![]() BMS-911543 |
|||
A4152-5 | ApexBio | 5 mg | EUR 244 |
Description: BMS-911543 is a selective small-molecule inhibitor of JAK2 with IC50 value of 1.1nM [1].BMS-911543 is a reversible pyrrolopyridine ATP-competitive JAK2 inhibitor with a high selectivity. |